Home > Healthcare > Biotechnology > Biotechnology R&D > Direct-to-Consumer (DTC) Genetic Testing Market

Direct-to-Consumer (DTC) Genetic Testing Market Share

Report ID: GMI3033
Published Date: Jan 2023
Report Format: PDF

Download Free Sample

Direct-to-Consumer (DTC) Genetic Testing Market Share

Some of the leading companies in the global direct-to-consumer genetic testing market include

Full Genome Corporation Inc.
23andMe, Inc.
Ancestry
Counsyl
Gene by Gene
Easy DNA
Helix OpCo LLC
Living DNA Ltd.
Karmagenes SA
Mapmygenome
Pathway genomics
Identigene
Genesis Healthcare Co.
The SkinDNA Company Pty Ltd
MyHeritage
Ambry Genetics
DNA Genotek Inc
Dante Lab
Blueprint Genetics Oy
DNA Diagnostic Center
HomeDNA

These participants are focusing on the development of novel products to strengthen their business identity.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global DTC genetic testing market was worth more than USD 3 billion in 2022 and is expected to witness over 11.5% CAGR from 2023-2032.

Single nucleotide polymorphism (SNP) chips is anticipated to exhibit over 12% CAGR over 2032 driven by their ability to improve the accuracy and efficiency of advanced DTC tests.

Europe DTC genetic testing market size is slated to reach over USD 2.7 billion by 2032 led by the presence of favorable initiatives catering to patients with rare disorders.

Ancestry, Counsyl, Easy DNA, Karmagenes SA, Mapmygenome, Identigene, MyHeritage, Dante Lab, and HomeDNA are some of the major companies in the market.